Literature meta-analysis about the efficacy of re-challenge with PD-1 and PD-L1 inhibitors in cancer patients
Élisa Gobbini, J. Charles, Anne‐Claire Toffart, M.‐T. Leccia, Denis Moro‐Sibilot, Matteo Giaj Levra
Topics & Concepts
MedicineInternal medicineOncologyHazard ratioPD-L1Lung cancerProgression-free survivalCancerPembrolizumabImmunotherapyOverall survivalConfidence intervalCancer Immunotherapy and BiomarkersColorectal and Anal CarcinomasColorectal Cancer Treatments and Studies